Abstract. The growth of A-1 fibroblasts depends on exogenous amyloid ~/A4 protein precursor (APP), providing a simple bioassay to study the function of APP. Our preliminary study, testing the activity of a series of fragments derived from the secreted form of APP-695 (sAPP-695) on this bioassay, has shown that at least one of the active sites of sAPP-695 was localized within a 40-mer sequence (APP296-335, Kang sequence; Roch, J.-M., I. P. Shapiro, M. P. Sundsmo, D. A. C. Otero, L. M. Refolo, N. K. Robakis, and T. Saitoh. 1992 . Z BioL Chem. 267:2214-2221. In the present study, to further characterize the growthpromoting activity of sAPP-695 on fibroblasts, we applied a battery of synthetic peptides on this bioassay and found that: (a) the sequence of five amino acids, RERMS (APP328-332), was uniquely required for the growth-promoting activity of sAPP-695; (b) the activity was sequence-specific because the reverse-sequence peptide of the active domain had no activity; and (c) the four-amino-acid peptide RMSQ (APP330-333), which partially overlaps the COOH-terminal side of the active sequence RERMS, could antagonize the activity of sAPP-695. Furthermore, a recombinant protein which lacks this active domain (APP20-591 without 306-335) did not promote fibroblast cell growth, suggesting that this domain is the only site of sAPP-695 involved in the growth stimulation. The availability of these biologically active, short peptides and their antagonists should prove to be an essential step for the elucidation of APP involvement in regulation of cellular homeostasis.
T rI~ amyloid/~/A4 protein is the major component of cerebrovascular amyloid deposits (Glenner and Wong, 1984) and the core of neuritic plaques (Masters et al., 1985; Selkoe et al., 1986) , the latter of which is believed to be the hallmark of the pathology found in brain tissue of patients afflicted with Alzheimer's disease (AD). l The protein is derived from a membrane-spanning protein, amyloid 8/ A4 protein precursor (APP) (Robakis et al., 1987; Kang et al., 1987; Goldgaber et al., 1987; Tanzi et al., 1987) , of which at least five different forms of primary translation products are now known. Three forms contain a domain showing a strong homology with protease inhibitors of the Kunitz type (KPI) whereas the other two forms (APP-695 and -714) do not Ponte et al., 1988; Tanzi et al., 1988; De Sauvage and Oc-tave, 1989; Golde et al., 1990) . Subsequent studies have shown the existence of secreted forms of APP (sAPP), either in the medium of cultured cells, such as PC12 and fibroblasts (Schubert et al., 1989a; U6da et al., 1989; Weidemann et al., 1989) , or in the cerebrospinal fluid (Palmert et al., 1989; Weidemann et al., 1989; Kitaguchi et al., 1990) . Since the identification of KPI-containing forms of sAPP as protease nexin II Van Nostrand et al., 1989) , many reports have appeared describing biological functions for these forms of sAPP. These include roles in the regulation of neurite extension Van Nostrand et al., 1989) , the blood coagulation process (Cole et al., 1990; Smith et al., 1990; Van Nostrand et al., 1990) , and the wound-healing process . Little is known, however, about the physiological function of sAPP-695 which lacks the KPI domain, in spite of the evidence indicating that APP-695 is the major form of APP mRNA in the brain Ponte et al., 1988; Tanaka et al., 1988; K6nig et al., 1991) . Curiously, however, at the protein level, it has been reported that APP-695 represents only a minor fraction of total brain APP . Nevertheless, the fact remains that APP-695 is found almost exclusively in brain tissue and i~ activity could underlie a brain-specific mechanism.
As an initial attempt to study physiological functions of APE we established a fibroblast cell line, A-l, transfected with a plasmid expressing an antisense APP RNA . This cell line produces very low levels of APP mRNA and its translation products, resulting in a slow growth rate. The growth of A-1 cells can be restored to the level of normal (parent) fibroblasts (AG2804) by the addition of exogenous APP, either APP-695 or APP-751/770, into the culture medium Bhasin et al., 1991) . Although the biochemical basis for the retarded growth rate of A-1 cells is still unclear, the dependence of the growth of cells on exogenous APP provided us with a rather simple bioassay for the functional mapping of APP (Roch et al., 1992) . Testing the activity of a series of sAPP-695 fragments obtained from our bacterial expression system on this bioassay, we have already shown that at least one of the sites of sAPP-695 responsible for the growth stimulation is located within a 40-mer sequence (APP296-335, Kang sequence) (Roch et al., 1992) .
In the present study, to further characterize the growthpromoting activity of sAPP-695 on fibroblasts, we addressed the following questions: (a) Which amino acid sequence within the 40-mer domain is essential for the activity? (b) Is the activity sequence-specific? (c) Does the 40-mer domain contain the only site of sAPP-695 capable of growth stimulation?
We found that the sequence of five amino acids, RERMS (APP328-332), was uniquely required for the growthpromoting activity of sAPP-695 on fibroblasts. We also found that the four-amino-acid peptide RMSQ (APP330-333), which partially overlaps the COOH-terminal side of the active sequence RERMS, could antagonize the activity of sAPP-695. These findings firmly establish the growthstimulating activity of sAPP-695 which lacks the KPI domain. The availability of these agonists and antagonists should be useful in further delineating the biological activity of sAPP-695 in physiological and pathological conditions.
Materials and Methods

Cell Culture
A-I and AG2804 fibroblasts were maintained as described previously . In brief, AG2804 cells were cultured in DME containing 10% FCS in 75-cm 2 flasks, at 37°C in 8% C(h, with one passage per week. A-1 cells were maintained in the same way with the exception that the media contained the conditioned media (CM) from AG2804 cell culture (20% vol/vol) . Inclusion of the CM from AG2804 ceils was necessary because the growth of A1 cells was significantly slower than that of AG2804 cells and was restored by the addition of the CM Bhasin et al., 1991) . To eliminate any residual effect of the CM, A1 cells used for the growth assay were kept in regular media (DME/10% FCS) without CM for 1 wk before the assay.
Growth Assays
Cells at 70-80% confiuency were detached from the substratum by incubating in PBS containing 1 mM EDTA. The detached cells were harvested, centrifuged, and resuspended in DME/10% FCS at a density of 5,000 ceUs/ml. The cell suspension was then seeded in six-well plates (2 ml/well) and the plates were kept at 37oc in a CO2 incubator for 1 h. The relevant peptide solution in DME (100 ~1) was then added. The same volume of DME without peptide was added in control wells. The plates were kept at 37°C in a CO2 incubator for 3 d and the cell number in each well was determined using a Coulter cell counter, model ZF (Coulter Electronics Inc., Hialeah, FL). The results were expressed as the percentage increase in the cell number compared to the number of the cells seeded. All the growth assays were done in triplicate. For the measurement of [3H]thymidine incorporation, the cells were washed after a 3-d incubation with DME and then incubated in DME containing [3H]thymidine (5 #Ci/ml, 1 nil/well Amersham Corp., Arlington Heights, IL) for 3 h at 37°C in a CO2 incubator. The cells were then fixed with 100% methanol/glacial acetic acid (1:3 vol/vol) and washed with ice-cold 10% TCA (0.5 ml x 5 times). The radioactivity remaining in the cells was extract~l by overnight incubation in 0.5 ml of 1 N NaOH and was counted in 10 ml of scintillation cocktail.
Preparation of Synthetic Peptides
A battery of peptides corresponding to all or part of APP296-335 (Table  I) were synthesized using a Rainin PS3 peptide synthesizer and purified on a C-18 reverse-phase HPLC column. Each peptide was recovered in 40% acetonitrile. This solvent was eliminated by evaporation under vacuum, and the peptide was resolubilized in 50 mM NaI-ICO3 (pH 7.4). Because both C6 and C7 peptides were insoluble in the buffer due to their hydrophobicity, they were first dissolved in DMSO and then diluted to give a final concentration of DMSO <0.01% in the assay media. The presence of 0.01% DMSO in the media did not affect the growth of AA cells (data not shown). All of the other peptides used were soluble in the sodium bicarbonate buffer.
Plasmid Construction and Bacterial Expression of KB75 (APP20-591, Kang Sequence) and KB758
(APP20-591 without 306-335)
The construction of pKB75, encoding the amino acids Val-20 to Ile-591 of APP-695, has been described (Roch et al., 1992) . The strategy for the construction of the plasmid pKB75~ is shown in Fig. 4 A. The oligonucleotides used as primers in the PCR were synthesized in a PCR-mate DNA synthesizer (Applied Biosystems, Inc., Foster City, CA) and purified by the oligonucleotide purification cartridge (OPC) system provided by the same supplier. The sequence of the 5' primer was 5'-GACAGTGTCACTCGA-GAGAGAATGGGAAGA~GAA-3' and the 3' primer was 5'-GGACTG-AGTCCTCGAGCTAGATCTCCTCCGTCTTGATATT-Y. The template for the PCR reaction was the 2.4-kb SmaI-Xmnl fragment of APP-695 eDNA. The reaction was carried out in 100 #1 PCR buffer containing 500 ng of template DNA, 1 #M of each primer, 200/~M of each dNTE and 1.5 U of the enzyme AmpliTaq. The sample was brought to a temperature of 94°C for 3 min, followed by 38 cycles of the following sequence: 940C for 30 s, 550C for 1 re_in, and 72°C for 1 rain. After the last cycle, a final extension step was performed at 72°C for 7 rain. The PCR product (800 bp in length) was finally purified by electrophoresis in 1% agarose gel, binding to a DEAE-cellulose membrane, elution in 1 M NaC1 at 65°C, and ethanol precipitation. The purified PCR product was then digested with XhoI restriction enzyme and ligated into the plasmid pKW/5 previously digested with XhoI and treated with canine intestine alkaline phosphatase. Competent Escherichia coil MCI061 cells were transformed with the ligation mixtures and clones were selected for ampicillin resistance. The size and orientation of the insert were determined by restriction analysis, using different enzymes having asymmetrical restriction sites. Positive clones were tested for expression of APP-derived peptides of appropriate size by immunoblotring with an anti-APP antibody (anti-GID) as described below. The new plasmid was named pKff758.
Immunoblotting
We used anti-GID antibody, a rabbit polyclonal antibody against the peptide 175-186 of APP Cole et al., 1991) , to verify the proteins expressed in bacteria. Proteins were separated by 8-16% PAGE in the presence of SDS (Laemmli, 1970) and transferred onto a nitrocellulose filter. After blocking the nonspecific binding site by incubation in PBS containing 0.1% Tween 20 (TPBS) for 1 h at room temperature, the filter was incubated overnight at 4°C in PBS containing 3% BSA and the antibody (1:2,000), washed five times for 5 rain in TPBS at room temperature, incubated 2 h at 4°C in PBS containing 3% BSA and t25I-protein A (Amersham Co., 0.3/~Ci/ml), washed again as described above, and exposed onto Kodak RP film for 2 h at room temperature.
Statistical Analysis
Experimental group comparisons of mean cell numbers and [3H]thymidine incorporations were performed by analysis of variance (ANOVA). The Dunnett's multiple comparison test was subsequently used to assess possible differences between the control group and the experimental groups, at the significance level of p < 0.05. The control group used in each experiment is indicated in each figure legend.
Results
In the previous report (Roch et al., 1992) , we showed that both KB75 (APP20-591) and a 40-mer peptide (APP296-335) were active on the A-1 cell growth assay. To find out the amino acid sequence within the 40-mer peptide which is essential for its activity, we synthesized a battery of peptides and tested their activity on the A-1 cell growth assay. The amino acid sequences of the synthetic peptides used are given in Table I . First, three peptides which covered the NH2-terminal (14-mer), mid-(13-mer), and COOH-terminal (17-mer) portions of the 40-mer were tested. Only the 17-mer was active (Fig. 1 A) . Second, two peptides which covered the NH2-terminal (8-mer) and COOH-terminal (11-mer) portions of the 17-mer were tested. Only the 11-mer was active (Fig. 1 B) . Third, six peptides which covered the NH2-terminal (N4 and N5), mid-(M5 and M6), and COOH-terminal (C6 and C7) portions of the 11-mer were tested. The M5 and M6 peptides were active, although the concentrations required for significant effects were ,,ol0-fold higher than those of other active peptides described above (Fig. 1 C) . Neither N4/N5 nor C6/C7 were active. The negative results for C7 (ERMSQVM) and C6 (RMSQVM) suggested that the NH2-terminal R and E residues of M5 (RERMS) were indispensable for the activity. To see whether the COOH-terminal S and M residues are dispensable or not, we tested M4 (RERM) and M3 (RER) and found no activity (Fig. 1 D) , suggesting that both of the COOHterminal residues were required for the activity. Thus, we have narrowed down the site responsible for the growth stimulation of fibroblasts to the five-amino-acid sequence RERMS (APP328-332, Kang sequence). To test the sequence specificity of the activity, we tested the reversesequence 17-mer and found no activity (Fig. 1 B) . As an additional parameter of cell growth, incorporation of [3H]-thymidine into the cells was determined. Three days exposure of cells to either KB75 or 17-mer (both at 10 pM) caused a significant increase in the incorporation (Fig. 2) reflecting an increase in the cell number per well, whereas neither 14-mer nor 13-mer caused higher levels of [3H]thymidine incorporation at the same concentrations, consistent with the results of cell numbers.
One possible mechanism for the action of these APP peptides is the interaction of APP with specific cell-surface molecule(s). The sequence specificity of the activity, as described above, seemed to support this idea. If this is the case, it is expected that the inactive peptides which partially overlap the active sequence RERMS might have an antagonistic action against the active peptides. According to this idea, we tested the activity of either 17-mer or KB75 (at 10 pM) in the presence of excess concentration (10 nM) of inactive peptides which partially overlaps RERMS, and we found that both C7 and C6, but not N4, antagonized the activity of the peptides (Fig. 3) . This antagonistic action was not an artifact caused by DMSO because C4 (RMSQ), a water-soluble derivative of C6, had a similar antagonistic action (Fig. 3) . C4 by itself had no growth-stimulating activity (data not shown).
The fact that the same peptide (C4) could antagonize the activities of either 17-mer or KB75 to a similar extent was indirect evidence that this domain (17-mer) represented the only active site of KB75. To see more directly whether this domain is the only active site of sAPP-695 or whether there is an additional active site, we engineered a construct which encodes APP20-591 without 306-335 (pKB75~5) (Fig. 4 A  and B) . Recombinant protein KB75c5 was obtained through bacterial expression and protein purification procedures, which were exactly the same as employed for the preparation of KB75 (Roch et al., 1992) . Immunoblotting with anti-GID antibody detected the expression of KB'/56 in the partially purified bacterial lysate, with a predicted difference in the molecular weight from that of KB75 (Fig. 4 C) . The peptide was further purified, through heparin-agarose column and Figure I . Growth-promoting activity of APP peptides on A-1 ceils. The growth assay on A-I cells was performed as described under Materials and Methods, using increasing concentrations of APP peptides. The amino acid sequence of each peptide is given in Table  I . In each panel, the lower dotted line and the shaded area represent the mean ± SEM of the percentage increase of A-I cell numbers after 3 d culture in the regular media (DME/ 10% FCS) (basal increase). As shown, the basal increase in the number of A-I cells was virtually zero. The upper dotted line and the shaded area represent the mean ± SEM of the percentage increase of AG2804 cell numbers after 3 d culture in the regular media, which was determined in parallel in each experiment. Each point represents the mean ± SEM of at least four determinations, each done in triplicate. * p < 0.05, significantly different from the basal increase (differences were assessed by ANOVA followed by the Durmett's test). The structure of pKB75 encoding APP20-591 was described in the previous report (Roch et al., 1992) . Using the APP-695 eDNA as a template, we carried out PCR to produce a DNA fragment coding for the APP-695 region extending from Arg-336 to I1e-591 (end of KB75). The PCR primers were designed so that this fragment would be flanked by two Xhol restriction sites, thus aUowing it to be easily ligated into the unique Xhol site of pKB75. This ligation resulted in a DNA fragment encoding a new version of KB75 where the domain extending from Thr-306 to Met-335 is deleted, therefore resulting in a fusion of Glu-305 to Arg-336. To prevent translation from proceeding beyond the BglII site, which would result in the production of an aberrant peptide, a STOP codon was included in the 3' primer of the PCR. (B) This scheme shows the regions of APP-695 encoded by the plasmids pKB75 and pKB75& None of them contains the signal sequence, or the O/A4, or the transmembraue or cytoplasmic domains. The KPI domain is shown only to indicate its insertion point in APP-751, but it is not present either in KB75 or KB75& (C) Identification of APP-related proteins in bacteria. SNiff fractions (25 ttg'of total protein in each lane) from bacteria carrying either pKB75 or pKB75# were prepared as described (Roch et al., 1992) , separated by SDS PAGE, and analyzed by immunoblotting with anti-GID antibody, diluted 1:2,000 (a rabbit polyclonal antibody against the peptide 175-186 of APP; see Saitoh et al., 1989) . As expected, the form of APP encoded by pKB756 was slightly smaller than that encoded by pKB75.
size-exclusion HPLC. The apparent homogeneity was judged by Coomassie blue staining of the gel after electrophoresis in the presence of SDS (data not shown). When KB756 thus verified was tested on A-1 cell growth assay, we could see no activity ( Fig. 5 ), in agreement with the suggestion that the sequence Thr-306 to Met-335 which was deleted in KB756 was essential for the activity. The purification of KB75/KB75~ from bacterial lysate involved the use of heparin-agarose column, in which we unexpectedly noticed that the ionic strength of NaC1 required for the elution of KB75~ was constantly lower than that required for the elution of KB75 (Fig. 6) , suggesting that the deleted sequence in KB756 contained a heparin-binding domain of KB75, or alternatively, the deletion caused a significant change in the structure of the molecule resulting in a reduced Figure 5 . KB756 lacked growth-promoting activity on A-1 cells. The growth assay on A-1 cells was performed using increasing concentrations of KW/5 or KB75& See legend to Fig. 1 for details. Each point represents the mean ± SEM of at least four determinations, each done in triplicate. *, p < 0.05, significantly different from the basal increase (differences were assessed by ANOVA followed by the Dunnett's test). Figure 6 . Elution profiles of KB75~, KW/5 and synthetic peptides from heparin-agarose column. SNI/I fractions from bacteria carrying either pKB75 or pKB758 were prepared as described (Roch et al., 1992) . 30 mg of total protein of each fraction were then mixed and loaded onto a heparin-agarose column, in PBS at 4°C (total amount of protein loaded, 60 mg). The flow-rate was 40 ml/h. Elution from the coluinn was monitored by absorbance at 280 nm (not shown). After washing with PBS, a linear gradient of NaCI (0.15-1.0 M) was run through the column. Fractions of 1 ml were collected. Aliquots of 25 #1 of each fraction were then analyzed by SDS PAGE and immunoblotting with the anti-GID antibody. Only the fractions containing APP-related proteins are shown on this figure and aligned with the profile of NaCI concentration. The elution profiles of KB75 and KB75~ were different. Consistent with our previous finding (Roch et al., 1992) , KW/5 was eluted at about 0.8 M NaCI. In contrast, KB756 was eluted at 0.45 M, showing thus a reduced affinity for heparin.
In another set of experiments, the synthetic peptide corresponding to the deleted sequence in KB75~ (40-met, open circles; 17-mer, closed circles), each 10 #g, was loaded to the same column and eluted in the same way. In this case, absorbance at 215 mn was monitored. As shown, both of the peptides were recovered in the flow-through fractions (PBS; 0.15 M NaCI), indicating the poor affinity of these peptides to heparin.
heparin-binding affinity. To see which was the case, we applied the synthetic peptides corresponding to the deleted sequence (i.e., 40-mer and 17-mer) to the same heparin affinity column but found no heparin-binding capacity for the peptides (Fig. 6) . Thus, although the deleted sequence in KB75~ might contribute to the heparin-binding capacity of sAPP-695 in an unknown way, the biological activity of the active domain included in the deleted sequence apparently is not due to heparin binding.
Discussion
We have mapped the growth-promoting activity of sAPP-695 to a domain of five amino acids RERMS (APP328-332) (Fig.  1) . The concentration of peptide needed for a significant effect, however, was 'M0-fold higher for RERMS than for either the 11-mer or 17-mer, suggesting that the amino acid sequence in the vicinity was necessary for the full activity. The reverse-sequence 17-mer had no activity (Fig. 1 C) , further indicating the sequence specificity of the activity. We also found that the four-amino-acid peptide RMSQ (APP330-333), which partially overlaps the COOH-terminal side of the active sequence RERMS could antagonize the activity of either the 17-mer or KI~5 (Fig. 3) . The lack of activity of KB755 in the A-1 cell bioassay can be explained if the deleted sequence in KB75~ (APP306-335) contains the only site capable of growth stimulation, or if a conformational modification results in a loss of activity. A change in conformation may be induced by the deletion of APP306-335 in KB756 because we observed a reduced affinity for heparin of KB75~ as compared to KB75, in spite of the absence of heparin-binding activity in the 40-mer and 17-mer peptides. However, the activity of KB75 could be totally antagonized by the tetramer RMSQ, indicating that the RERMS domain is uniquely responsible for the growth promotion, and that no other site in KB75 could stimulate the growth of fibroblasts.
The RERMS motif and its NH~-terminal side amino acid sequence have some interesting characteristics. First, the sequence RERMS is unique to APP; we found no match in the peptide sequences so far registered in GenBank. Second, it is within one of the evolutionarily highly conserved regions of APP (Rosen et al., 1989) . Exactly the same sequence as 40-met is found in mammalian APPs (rat, mouse, and monkey). In the Drosophila "APP-like" molecule, there is a sequence REKVT (aa 423-427; Rosen et al., 1989) ; the polarity of the side chains of the corresponding residues is very similar to RERMS (K and R have basic, V and M have nonpolar, and T and S have uncharged polar side chains, respectively). The uniqueness and the high evolutionary conservation both suggest the fundamental role of the sequence in the physiological function(s) of sAPP.
We could thus identify a unique region of APP which was active on our A-1 cell bioassay. The biochemical mechanism of the activity, however, is still unknown. In previous reports Roch et al., 1992) , we proposed two possible mechanisms. The first is the possible effect of APP on A-1 cell adhesion. Many reports have suggested the role of APP in cell adhesion (Shubert et al., 1989a; Breen et al., 1991; Chen and Yankner, 1991) . APP binds to heparansulfate proteoglycan (Narindrasorasak et al., 1991) , which is supposed to be involved in cell-extracellular matrix interaction. Our preliminary experiments indicated a significant reduction in the adhesiveness of A1 cells compared to that of the parent cells, AG2804 (data not shown). Because we have not been able, so far, to increase the adhesiveness of A-1 cells using soluble or immobilized KB75, more work is needed for a better understanding of the involvement of APP in cell adhesion. It is possible that co-and post-translational processing, such as glycosylation, or transmembrane config-uration, in contrast to secreted form, are required for the cell adhesive property of APP. The second possible mechanism we proposed is the effect(s) of sAPP on the intracellular signal transduction machineries through an interaction with cell-surface receptor molecule(s). The sequence specificity of the activity and the antagonistic actions of partially overlapping, inactive peptides are compatible with this notion, although direct evidence for the presence of a cell-surface recognition molecule for sAPP is still lacking.
APP is one of the hepafin-binding proteins (Schubert et al., 1989b) , the reason why we used heparin-agarose column to purify it from the bacterial lysate (Roch et al., 1992) . In the course of purification of KB75 and KB758 expressed in bacteria, we noticed that the binding affinity of KI~58 to heparin-agarose column was lower than that of KB75 (Fig.  6) . The lack of the heparin-binding capacity of biologically active, synthetic peptides corresponding to the deleted sequence in KB758 (Fig. 6) , however, excluded the active involvement of the binding to heparin or heparinlike molecules, which are presumably present in the assay media or on the cell surface, in the growth-promoting activity. Further evidence for the absence of contribution of heparin-binding capacity to the activity is that the inclusion of either heparin or heparan sulfate in the assay media (both at 100 #g/rnl) failed to inhibit the effect of either 17-mer or KB75 (data not shown). A potential heparin-binding site on sAPP-695 predicted from the consensus sequence (Cardin and Weintraub, 1989) is not on the active domain but on APP98-104 (Narindrasorasak et al., 1991). Thus, although the sequence APP306-335 may contribute to the heparin-binding capacity of sAPP-695 in its native form of the molecule, the growthpromoting activity of the domain in itself had little to do with the heparin-binding capacity.
In summary, using our bioassay on A-1 cells, we showed that the site of sAPP-695 responsible for the growth stimulation is represented by the five-amino-acid sequence RERMS (APP328-332), and that this site is unique in the APP molecule. The biochemical basis for the activity is still unknown. Recent studies in our laboratory have revealed that the biological activity of this domain of sAPP is not confined to this particular cell line; the addition of synthetic peptides corresponding to this domain to the culture media caused significant morphological and biochemical changes in either neuroblastoma cells from rat brain or primary cortical neurons from newborn rat (manuscript in preparation). Thus, sAPP seems to be involved in the regulation of cellular homeostasis in various cell lines. In a previous study, we found that cultured fibroblasts from the skin of AD patients These findings raised a possibility that, in addition to the COOHterminal ~/A4 portion of APP which is involved in amyloidogenesis, the secreted portion of APP is also involved in the pathogenesis of AD. We expect that the biologically active peptides and their antagonists described in the present study will be useful tools to study the possible involvement of the biological activity of sAPP-695 in various experimental model systems for the pathogenesis of AD.
